OpenURL Connection Search

Select item for more details and to access through your institution.

Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
Published in:
Open Forum Infectious Diseases, 2023, v. 10, n. 12, p. 1, doi. 10.1093/ofid/ofad598
By:
- Xu, Meng;
- O'Brien, Meagan P;
- Hooper, Andrea T;
- Forleo-Neto, Eduardo;
- Isa, Flonza;
- Hou, Peijie;
- Chan, Kuo-Chen;
- Cohen, Myron S;
- Marovich, Mary A;
- Hamilton, Jennifer D;
- Hirshberg, Boaz;
- Herman, Gary A;
- Musser, Bret J
Publication type:
Article
A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.
Published in:
Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad271
By:
- Brown, Elizabeth R;
- O'Brien, Meagan P;
- Snow, Brian;
- Isa, Flonza;
- Forleo-Neto, Eduardo;
- Chan, Kuo-Chen;
- Hou, Peijie;
- Cohen, Myron S;
- Herman, Gary;
- Barnabas, Ruanne V
Publication type:
Article
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.
Published in:
2020
By:
- Worm, Margitta;
- Simpson, Eric L.;
- Thaçi, Diamant;
- Bissonnette, Robert;
- Lacour, Jean-Philippe;
- Beissert, Stefan;
- Kawashima, Makoto;
- Ferrándiz, Carlos;
- Smith, Catherine H.;
- Beck, Lisa A.;
- Chan, Kuo-Chen;
- Chen, Zhen;
- Akinlade, Bolanle;
- Hultsch, Thomas;
- Staudinger, Heribert;
- Gadkari, Abhijit;
- Eckert, Laurent;
- Davis, John D.;
- Rajadhyaksha, Manoj;
- Graham, Neil M. H.
Publication type:
journal article
A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteers.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 283, doi. 10.1111/dom.13075
By:
- Kostic, Ana;
- King, Thomas Alexander;
- Yang, Feng;
- Chan, Kuo‐Chen;
- Yancopoulos, George D.;
- Gromada, Jesper;
- Harp, Joyce B.
Publication type:
Article
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Published in:
Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39292-w
By:
- Follmann, Dean;
- O'Brien, Meagan P.;
- Fintzi, Jonathan;
- Fay, Michael P.;
- Montefiori, David;
- Mateja, Allyson;
- Herman, Gary A.;
- Hooper, Andrea T.;
- Turner, Kenneth C.;
- Chan, Kuo- Chen;
- Forleo-Neto, Eduardo;
- Isa, Flonza;
- Baden, Lindsey R.;
- El Sahly, Hana M.;
- Janes, Holly;
- Doria-Rose, Nicole;
- Miller, Jacqueline;
- Zhou, Honghong;
- Dang, Weiping;
- Benkeser, David
Publication type:
Article
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
Published in:
2022
By:
- O'Brien, Meagan P.;
- Forleo-Neto, Eduardo;
- Sarkar, Neena;
- Isa, Flonza;
- Hou, Peijie;
- Chan, Kuo-Chen;
- Musser, Bret J.;
- Bar, Katharine J.;
- Barnabas, Ruanne V.;
- Barouch, Dan H.;
- Cohen, Myron S.;
- Hurt, Christopher B.;
- Burwen, Dale R.;
- Marovich, Mary A.;
- Brown, Elizabeth R.;
- Heirman, Ingeborg;
- Davis, John D.;
- Turner, Kenneth C.;
- Ramesh, Divya;
- Mahmood, Adnan
Publication type:
journal article

Found: 6

Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.

A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.

A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteers.

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.